Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

NCT02031861 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: nifedipine CR tablets (Xin Ran)
DRUG: nifedipine CR tablets (Adalat)

Sponsor

Shanghai Shyndec Pharmaceutical Co., Ltd.